LivaNova PLC
Revenue Breakdown
| Fiscal Year | Neuromodulation | Cardiovascular | CRM | Other |
|---|---|---|---|---|
| FY2006 | $113.8M | $0 | $0 | $0 |
| FY2007 | $118.8M | $0 | $0 | $0 |
| FY2008 | $125.7M | $0 | $0 | $0 |
| FY2009 | $146.4M | $0 | $0 | $0 |
| FY2010 | $163.7M | $0 | $0 | $0 |
| FY2011 | $192.4M | $0 | $0 | $0 |
| FY2012 | $218.7M | $0 | $0 | $0 |
| FY2013 | $255.4M | $0 | $0 | $0 |
| FY2014 | $282.2M | $0 | $0 | $0 |
| FY2016 | $351.0M | $569.2M | $233.7M | $600.0K |
| FY2017 | $389.2M | $613.8M | $247.1M | $500.0K |
| FY2018 | $443.3M | $633.4M | $0 | $800.0K |
| FY2019 | $472.9M | $610.7M | $0 | $600.0K |
| FY2020 | $403.2M | $530.0M | $0 | $800.0K |
| FY2021 | $491.5M | $542.4M | $0 | $1.0M |
| FY2022 | $545.9M | $475.6M | $0 | $800.0K |
| FY2023 | $618.3M | $530.1M | $0 | $1.2M |